Department of Health Sciences, School of Dentistry, University of L'Aquila, L'Aquila, Italy.
J Periodontol. 2013 Jul;84(7):958-73. doi: 10.1902/jop.2012.120377. Epub 2012 Oct 29.
It was recently suggested that scaling and root planing (SRP) may help to improve glycemic and metabolic control in patients with chronic periodontitis (CP) and type 2 diabetes mellitus (DM2); however, the effectiveness of SRP in this role remains unclear. This meta-analysis assesses the effectiveness of SRP in improving glycemic and metabolic control in patients with CP and DM2.
A literature search of electronic databases was performed for articles published through May 16, 2012, followed by a manual search of several dental journals. A meta-analysis was conducted according to the recommendations of the Cochrane Collaboration and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Weighted mean differences (MDs) and 95% confidence intervals (CIs) were calculated for glycated hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), total cholesterol (TC), triglycerides (TG), and high- and low-density lipoprotein cholesterol (HDL and LDL, respectively). All outcomes were evaluated as changes from baseline to the end of follow-up. Heterogeneity was assessed with the χ(2)-based Cochran Q test and I(2) statistic. The level of significance was set at P <0.05.
After the study selection process, five randomized clinical trials were included. Results of the meta-analysis indicated that SRP was effective in the reduction of HbA1c (MD = 0.65; 95% CI 0.43 to 0.88; P <0.05) and FPG (MD = 9.04; 95% CI 2.17 to 15.9; P <0.05), but no significant differences were found in the reduction of TC, TG, HDL, or LDL. No evidence of heterogeneity was detected.
The meta-analysis results seem to support the effectiveness of SRP in the improvement of glycemic control in patients with CP and DM2; however, future studies are needed to confirm these results.
最近有人提出,牙周刮治和根面平整(SRP)可能有助于改善患有慢性牙周炎(CP)和 2 型糖尿病(DM2)的患者的血糖和代谢控制;然而,SRP 在这方面的有效性尚不清楚。本荟萃分析评估了 SRP 在改善 CP 和 DM2 患者血糖和代谢控制方面的有效性。
对截至 2012 年 5 月 16 日发表的文献进行电子数据库检索,然后对几个牙科期刊进行手工检索。根据 Cochrane 协作组织和系统评价和荟萃分析的首选报告项目(PRISMA)的建议进行荟萃分析。计算糖化血红蛋白 A1c(HbA1c)、空腹血糖(FPG)、总胆固醇(TC)、甘油三酯(TG)以及高密度和低密度脂蛋白胆固醇(HDL 和 LDL,分别)的加权均数差值(MD)和 95%置信区间(CI)。所有结果均作为从基线到随访结束的变化进行评估。采用基于 χ(2)的 Cochran Q 检验和 I(2)统计量评估异质性。显著性水平设为 P <0.05。
经过研究选择过程,纳入了五项随机临床试验。荟萃分析结果表明,SRP 可有效降低 HbA1c(MD = 0.65;95%CI 0.43 至 0.88;P <0.05)和 FPG(MD = 9.04;95%CI 2.17 至 15.9;P <0.05),但在 TC、TG、HDL 或 LDL 的降低方面无显著差异。未检测到异质性。
荟萃分析结果似乎支持 SRP 在改善 CP 和 DM2 患者血糖控制方面的有效性;然而,需要进一步的研究来证实这些结果。